Huifeng
Yue‡
a,
Chen
Zhu‡
a,
Li
Shen
a,
Qiuyang
Geng
a,
Katharina J.
Hock
a,
Tingting
Yuan
a,
Luigi
Cavallo
*b and
Magnus
Rueping
*ab
aInstitute of Organic Chemistry, RWTH Aachen University, Landoltweg 1, D-52074 Aachen, Germany. E-mail: magnus.rueping@rwth-aachen.de
bKAUST Catalysis Center, KCC, King Abdullah University of Science and Technology, KAUST, Thuwal 23955-6900, Saudi Arabia
First published on 20th March 2019
Nickel-catalyzed reductive cross coupling of activated primary amines with aryl halides under mild reaction conditions has been achieved for the first time. Due to the avoidance of stoichiometric organometallic reagents and external bases, the scope regarding both coupling partners is broad. Thus, a wide range of substrates, natural products and drugs with diverse functional groups are tolerated. Moreover, experimental mechanistic investigations and density functional theory (DFT) calculations in combination with wavefunction analysis have been performed to understand the catalytic cycle in more detail.
Scheme 1 Diverse activation modes of pyridinium salts and the advantages of this novel deaminative reductive cross-coupling protocol. |
Entry | [Ni] | Ligand | Reductant | Solvent | Yieldb (%) |
---|---|---|---|---|---|
a Reaction conditions: Katritzky pyridinium salt 1a (0.1 mmol), iodobenzene 2a (0.1 mmol), [Ni] (0.01 mmol), ligand (0.01 mmol), reductant (2 equiv.) in 1.0 ml solvent at rt. b GC yield using decane as the internal standard. c The ratio of 1a to 2a was set at 1.5:1. d The ratio of 1a to 2a was set at 1:2. e Bromobenzene was used instead of iodobenzene. | |||||
1 | NiCl2·dme | L1 | Zn | DMA | 29 |
2 | NiCl2·dme | L1 | Zn | DMF | 11 |
3 | NiCl2·dme | L1 | Zn | CH3CN | 10 |
4 | NiCl2·dme | L1 | Zn | THF | 16 |
5 | NiCl2·dme | L1 | Zn | Toluene | 0 |
6c | NiCl2·dme | L1 | Zn | DMA | 61 |
7d | NiCl2·dme | L1 | Zn | DMA | 36 |
8c | NiCl2·dme | L2 | Zn | DMA | 61 |
9c | NiCl2·dme | L3 | Zn | DMA | 49 |
10c | NiCl2·dme | L4 | Zn | DMA | 60 |
11c | NiBr2·dme | L2 | Zn | DMA | 51 |
12c | Ni(OAc)2·4H2O | L2 | Zn | DMA | 15 |
13c | Ni(acac)2 | L2 | Zn | DMA | 35 |
14c | NiCl2·6H2O | L2 | Zn | DMA | 35 |
15c | NiCl2·dme | L2 | Mg | DMA | 8 |
16c | NiCl2·dme | L2 | Mn | DMA | 99 |
17c,e | NiCl2·dme | L2 | Mn | DMA | 81 |
18c | — | L2 | Mn | DMA | 0 |
19c | NiCl2·dme | — | Mn | DMA | 6 |
20c | NiCl2·dme | L2 | — | DMA | 0 |
With the optimized reaction conditions in hand, the scope of aryl halides was first evaluated (Table 2a). A wide variety of aryl halides bearing electron-donating, electron-neutral, and electron-withdrawing functional groups could be successfully converted into the corresponding products in good to excellent yields. For example, phenyl and biphenyl iodides and bromides underwent this reaction smoothly, giving the corresponding products in excellent yields (3a and 3b).
a Reaction conditions: pyridinium salt 1 (0.30 mmol), aryl halide 2 (0.20 mmol), NiCl2·dme (0.02 mmol), L2 (0.02 mmol, for secondary alkyl) or L4 (0.02 mmol, for primary alkyl), Mn powder (0.40 mmol) in 1.0 ml DMA at rt (for secondary alkyl) or 60 °C (for primary alkyl); yields after purification. b GC yield. c The ratio of pyridinium salt to aryl halide 1:3, 100 °C, NMR yield. |
---|
In addition, a wide range of functional groups including ketone (3c and 3d), trifluoromethyl (3e), trifluoromethoxy (3f), trifluoromethylthio (3g), tosyl (3h), cyano (3i and 3m), methoxy (3j), methylthio (3k), t-butyl (3l), fluoro (3m, 3r and 5k), and ester (5j) were well tolerated under the mild reaction conditions, highlighting the high chemoselectivity of this newly developed deaminative reductive cross-coupling reaction. Use of disubstituted aryl bromide and bicyclic substrates including phthalides and naphthyl halides also gave the products 3m–3p in good yields. It is noteworthy that pharmaceutically relevant 3- and 4- bromopyridines could be applied to this protocol with good to high efficiency (3q–3s, 5n). Next, the scope of pyridinium salts was explored. A wide range of structurally diverse pyridinium salts were suitable substrates for this transformation. Cyclic and acyclic secondary amine substrates could undergo this deaminative arylation reaction in good to excellent yield (4a–4g) and the same applies for N-heterocyclic pyridinium salts (4h and 4i) (Table 2b).
It should be mentioned that when we applied primary alkyl pyridinium salts to this protocol, the reaction did not occur. However, simply switching the ligand from L2 to L4 and slightly raising the reaction temperature to 60 °C allowed this transformation to occur smoothly. A series of primary alkyl pyridinium salts bearing diverse functional groups such as amine, acetal, dioxole, cyclohexenyl, thiophene, and pyridine were suitable coupling partners for this deaminative reductive cross-coupling, leading to products 4n–4s. Notably, chloro (4k), unprotected OH and indole NH groups were also tolerated (4t and 5f), providing the option for further functionalization. Moreover, methylation reaction, which is challenging in reductive cross-coupling, was also realized via the utilization of methyl pyridinium salts (Table 2c). Importantly, our newly developed protocol could also be readily extended to a wide range of complex molecules derived from natural products and drugs. As such pregnenolone, galactopyranose, probenecid, adamantane carboxylic acid, and cholestanol derivatives could be transformed to the corresponding products 5a–5e in good to excellent yield. Moreover, a series of pyridinium salts derived from drugs or drug intermediates, including tryptamine, mexiletine, amphetamine, Lipitor intermediate, and dopamine, all underwent the mild coupling protocol with good to excellent efficiency (5f–5n). Use of Mosapride derived pyridinium salts gave product 5o in a lower yield (Table 2d).
Additionally, a gram-scale reaction was successfully conducted using 1a and 4-iodobiphenyl 2b in the presence of only 5 mol% nickel catalyst and the desired product 3b was obtained in 96% yield (Scheme 2a), demonstrating the practicability of our newly developed deaminative reductive cross-coupling methodology. Also, byproduct 6, which is potentially a useful organic base, could be isolated in 85% yield. To shed light on the mechanism of this transformation, an experiment was conducted with the radical trapping reagent TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy, 2 equiv.).5a,c The reaction was suppressed and no product 5m was detected (Scheme 2b).
Also, ring-opened product 9 was generated in 55% yield when a substrate bearing a cyclopropane motif 8 was used (Scheme 2c).5a,c Both these results suggest the involvement of an alkyl radical in this transformation. When ligand L5 which is effective for chain-walking reductive cross-coupling10 was used in our catalytic system, non-walking and chain-walking products (4e and 4e′, 5h and 5h′) were obtained with a ratio of 4:1, suggesting an oxidative addition of aryl halide to Ni0 to give a NiII intermediate prior to alkyl radical generation. Since the NiIII intermediate generated from addition of the alkyl radical to the NiII intermediate is less likely to undergo the chain-walking step due to steric hindrance the non-chain-walking product is the major product.
Furthermore, detailed DFT calculations were performed to rationalize our newly designed catalytic reaction (Scheme 3; computational methods, see ESI†). As a model system, we investigated the reaction of phenyl bromide with A1 in the presence of NiCl2·dme, bpy as the ligand and Mn as the reducing agent. The reaction starts with the complexation of the ligand bpy to the NiII precatalyst, followed by reduction to form the active Ni0 catalyst B (Scheme S1 in ESI†). The catalytic process is initiated by oxidative addition of phenyl bromide to Ni0via transition state B-TS with an energy barrier of 11.7 kcal mol−1. The formed NiII intermediate C is reduced by Mn, leading to intermediate D with a free energy gain of 6.9 kcal mol−1. In the next step, A1 is coordinated to D, followed by SET reduction of A1 to generate radical A2 and NiII intermediate F. The radical A2 is prone to undergo C–N bond cleavage with an energy barrier of 19.9 kcal mol−1, liberating the alkyl radical A3 and the aromatic pyridine A4. At this point, alkyl radical A3 adds to NiII intermediate F to form NiIII intermediate G. Subsequently, the C–C bond cross-coupling product A5 is formed via reductive elimination from NiIII with an energy barrier of 4.9 kcal mol−1.
Finally, the NiI intermediate H is further reduced by Mn to regenerate the Ni0 active catalyst B and initiate the next catalytic cycle.
Subsequently, we focused on the origin of the SET reduction of the pyridinium salt and the generation of the alkyl radical.11 The molecular orbital plots (Fig. 1a) show that the SOMO of E corresponds to the singly occupied MO predominantly localized on the dz2-orbital of Ni. At the same time, the LUMO of E corresponds to a π-orbital delocalized around the central nitrogen-containing aromatic ring of the pyridinium salt. However, after A2 is displaced away from the Ni species, the SOMO becomes localized on the central aromatic ring of the pyridinium salt. This indicates that upon separation of the Ni and pyridyl fragments the unpaired electron transfers from Ni to the pyridinium salt and delocalizes around the central aromatic ring. Spin density analysis further supported this process. The unpaired electron density is localized on the Ni-center when the pyridinium salt is coordinated to the NiI-complex, as in E (Fig. 1b, left), while it is transferred to the central pyridine ring as the pyridine moiety A2 dissociates from the Ni complex (Fig. 1b, middle). Subsequently, the C–N bond dissociates and the spin density is further transferred to the sp3-carbon atom, indicating generation of the alkyl radical (Fig. 1b, right). Additionally, cyclic voltammetry (CV) measurements of the pyridinium salt were conducted (see ESI†) and reversible peaks at −0.94 V vs. SCE were observed, suggesting the existence of stable radical intermediate A2. In order to understand the C–N bond dissociation, we performed localized orbital locator (LOL) – π analysis12 and multi-center bond order calculations (Iring)13 for the whole process (Fig. 1c). Before the SET reduction, the central pyridine ring has full aromaticity (Iring = 0.05 in A1, for comparison, Iring = 0.05 in benzene and pyridine12c). After the reduction the aromaticity is lost and the free energy is 3.0 kcal mol−1 higher (Iring = 0 in A2). With the C–N bond dissociating, the aromaticity is partially regained (c.f. Iring = 0.01 in transition state A2TS). After the generation of alkyl radicals, the aromaticity of A3 is fully restored (Iring = 0.05 in A3) with a free energy gain of 5.5 kcal mol−1.
Footnotes |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc00783k |
‡ These authors contributed equally to this work. |
This journal is © The Royal Society of Chemistry 2019 |